Outcomes of changing systemic therapy in patients with relapsed breast cancer and 1 to 3 brain metastases

por Alhalabi, Omar, Soomro, Zaid, Sun, Ryan, Hasanov, Elshad, Albittar, Aya, Tripathy, Debu, Valero, Vicente, Ibrahim, Nuhad K.
Publicado 2021

P616: LONG-TERM FOLLOW-UP UPDATE AND MULTIVARIABLE ANALYSES OF FACTORS ASSOCIATED WITH DURATION OF RESPONSE AFTER CD19 CAR T-CELL THERAPY FOR RELAPSED/REFRACTORY CLL

por Liang, Emily, Hirayama, Alexandre, Kimble, Erik, Portuguese, Andrew, Albittar, Aya, Chapuis, Aude, Shadman, Mazyar, Till, Brian, Cassaday, Ryan, Milano, Filippo, Kiem, Hans-Peter, Turtle, Camesron, Maloney, David, Gauthier, Jordan
Publicado 2023

Factors associated with long-term outcomes of CD19 CAR T-cell therapy for relapsed/refractory CLL

por Liang, Emily C., Albittar, Aya, Huang, Jennifer J., Hirayama, Alexandre V., Kimble, Erik L., Portuguese, Andrew J., Chapuis, Aude, Shadman, Mazyar, Till, Brian G., Cassaday, Ryan D., Milano, Filippo, Kiem, Hans-Peter, Riddell, Stanley R., Turtle, Cameron J., Maloney, David G., Gauthier, Jordan
Publicado 2023

Incidence and Risk Factors for Pneumonitis Associated With Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer: A Single Center Experience

por Altan, Mehmet, Soto, Felipe, Zhong, Linda L, Akhmedzhanov, Fechukwu O, Wilson, Nathaniel R, Zarifa, Abdulrazzak, Albittar, Aya A, Yang, Vincent, Lewis, Jeff, Rinsurongkawong, Waree, Jack Lee, J, Rinsurongkawong, Vadeerat, Zhang, Jianjun, Gibbons, Don L, Vaporciyan, Ara A, Jennings, Kristofer, Khawaja, Fareed, Faiz, Saadia A, Shannon, Vickie R, Shroff, Girish, Godoy, Myrna C B, Daver, Naval G, Gandhi, Saumil, Mendoza, Tito R, Naing, Aung, Daniel-MacDougall, Carrie, Heymach, John V, Sheshadri, Ajay
Publicado 2023